Investment Dealflow Within The KapVista Ecosystem

Heading into February, our team is keeping tabs on the trends in the capital raising space, and matching them to best deals from our ecosystem. We wanted to share with you some of the most promising ones.

eCommerce: e-retail revenues are projected to grow to 6.54 trillion US dollars in 2022

A one-stop e-commerce research platform that allows users to research and purchase products with over 4k registered users on the platform, 40+ affiliate partners, and a strategic partnership with Edge196 LLC, opening avenues to a marketplace in a cross-border ecosystem. ► Register interest in iuzeit.

Almost 70% of American smokers want to quit but only 6% succeed

Quitta has developed a nicotine metered-dose inhaler that manages cravings quickly, safely, and discreetly. The finished product is double the efficacy of patches, and acts 3x faster than its closest competitor and pre-negotiated requirements for first developed-world medicine approval. ► Register interest in Quitta.

1.17B women globally suffer “period pain”, opening an opportunity to service a target market of 690M

Bioactive Laboratories developed Khapregesic®, a fast-acting non-drug alternative to relieve pain from various conditions. The finished product holds IP and trade secrets protection and has been clinically tested & regulatory approved. 100+ Customers & Resellers. ► Register interest in Bioactive Labs.

AI market is forecast to grow rapidly to reach 126 billion U.S. dollars by 2025

BlackArrow developed an AI-backed open banking solution to simplify user’s financial journey, led by a CEO with over 6 years experience across FinTech & RegTech and 20+ yrs in banking & tech and is scaling rapidly across the UK with key partnerships.
► Register interest in BlackArrow.

If you have any questions about any of the above offers, let us know.

© 2020 KapVista